Eli Lilly profit drops sharply as Zyprexa medication goes generic

INDIANAPOLIS – Eli Lilly & Co’s. quarterly profit dropped 27 percent after its top-selling Zyprexa schizophrenia treatment lost U.S. patent protection and saw competition from generic rivals. The drugmaker backed its 2012 outlook that calls for a steep drop in profit this year due largely to the Zyprexa loss. It said an independent safety committee […]